Irinotecan injures tight junction and causes bacterial translocation in rat

Journal of Surgical Research

Volumn 173, Issue 2, 2012, Pages 341-347

  Nakao, Toshihiro ^a   Kurita, Nobuhiro ^a   Komatsu, Masato ^a   Yoshikawa, Kozo ^a   Iwata, Takashi ^a   Utusnomiya, Toru ^a   Shimada, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

bacterial translocation; irinotecan; tight junction

Indexed keywords

CLAUDIN 1; IRINOTECAN; OCCLUDIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DIARRHEA; INTESTINE EPITHELIUM; LARGE INTESTINE; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMALL INTESTINE; SPLEEN; TIGHT JUNCTION; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BACTERIAL TRANSLOCATION; CAMPTOTHECIN; DIARRHEA; INTESTINAL MUCOSA; MALE; MEMBRANE PROTEINS; PERMEABILITY; RATS; RATS, WISTAR; RNA, MESSENGER; TIGHT JUNCTIONS; WEIGHT LOSS;

EID: 84858282686     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.10.003     Document Type: Article

References (20)

1. Hollander D. Crohn's disease - A permeability disorder of the tight junction? Gut 1988;29:1621.
2. Madara JL. Loosening tight junctions. Lessons from the intestine. J Clin Invest 1989;83:1089.
3. Ma TY, Iwamoto GK, Hoa NT, et al. TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am J Physiol Gastrointest Liver Physiol 2004; 286:367.
4. González-Mariscal L, Betanzos A, Nava P, et al. Tight junction proteins. Prog Biophys Mol Biol 2003;81:1.
5. Zulfikaroglu B, Zulfikaroglu E, Ozmen MM, et al. The effect of immunonutrition on bacterial translocation, and intestinal villus atrophy in experimental obstructive jaundice. Clin Nutr 2003;22:277.
6. Ellis M. Preventing microbial translocation in haematological malignancy. Br J Haematol 2004;125:282.
7. Kawato Y, Aonuma M, Hirota Y, et al. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 1991;51:4187.
8. Ikegami T, Ha L, Arimori K, et al. Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea. Cancer Res 2002;62:179.
9. Gupta E, Lestingi TM, Mick R, et al. Metabolic fate of irinotecan in humans: Correlation of glucuronidation with diarrhea. Cancer Res 1994;54:3723.
10. Takasuna K, Hagiwara T, Hirohashi M, et al. Involvement of β-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res 1996;56:3752.
11. Brandi G, Dabard J, Raibaud P, et al. Intestinal microflora and digestive toxicity of irinotecan in mice. Clin Cancer Res 2006; 12:1299.
12. Gibson RJ, Bowen JM, Inglis MR, et al. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 2003; 18:1095.
13. Eizaguirre I, Urkia NG, Asensio AB, et al. Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J Pediatr Surg 2002;37:699.
14. Brun P, Castagliuolo I, Di Leo V, et al. Increased intestinal permeability in obese mice: New evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007;292:G518.
15. Kucharzik T, Walsh SV, Chen J, et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001;159:2001.
16. Inoue K, Oyamada M, Mitsufuji S, et al. Different changes in the expression of multiple kinds of tight-junction proteins during ischemia-reperfusion injury of the rat ileum. Acta Histochem Cytochem 2006;39:35.
17. Shao L, Huang Q, He M, et al. Changes of occludin expression in intestinal mucosa after burn in rats. Burns 2005; 31:838.
18. Ikuno N, Soda H, Watanabe M, Oka M. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. J Natl Cancer Inst 1995;87:1876.
19. Clark JA, Doelle SM, Halpern MD, et al. Intestinal barrier failure during experimental necrotizing enterocolitis: Protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 2006;291:G938.
20. MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull 2004;71:1.